The pharmaceutical landscape for metabolic health is undergoing a seismic shift. For years, the narrative surrounding weight...
Treatment Innovations
In a landmark development for consumer health technology, Samsung Electronics has secured US Food and Drug Administration...
By Jonathan Gardner, Biopharma Dive Published August 14, 2026 In a pivotal moment for hematology and the...
In a landmark decision that promises to reshape the global approach to viral hepatitis, the European Commission...
In a significant move poised to reshape the landscape of interventional pulmonology, Japanese medtech giant Olympus has...
The landscape of pharmaceutical manufacturing is undergoing a profound structural shift. As global life sciences companies pour...
The landscape of biotechnology in 2026 is defined by a paradox: while capital markets remain cautious, the...
For over a decade, the American Society of Clinical Oncology (ASCO) maintained CancerLinQ, a pioneering initiative designed...
In a significant development for the field of interventional radiology and vascular surgery, Texas-based medical device manufacturer...
By Jonathan Gardner | Published August 13, 2026 The landscape for treating EGFR exon 20 insertion-mutated non-small...
